Dr. Amitabh N. Chak, MD

Dr. Chak practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Chak's NPI, 1841215332, was assigned on July 13, 2006. Dr. Chak holds Ohio license 35-061996.

Dr. Chak's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Chak's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Chak is also affiliated with University Hospitals Ahuja Medical Center. The medical group on file is University Hospitals Medical Practices.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chak practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Chak's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Chak is licensed in Ohio.

CMS data shows 81 Medicare services from Dr. Chak across 5 procedure codes in 2024, for 130 Medicare patients. Medicare paid $4,557 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 130 Medicare patients who saw Dr. Chak in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chak's median patient age at 71, with 43% women.

In 2024, Dr. Chak wrote 147 Medicare Part D claims for 33 patients. 83% of them were for generic drugs. CMS names the drug for 96 of them, across 4 drugs with 11 or more claims each, at $23,508 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Chak for performance year 2024, reported as part of a group. Dr. Chak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chak as offering telehealth. CMS counts 171 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Chak, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 84 papers to Dr. Chak, published from 2015 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Barrett Esophagus, Esophageal Neoplasms and Adenocarcinoma. Dr. Chak has published most often in Gastrointest Endosc. Dr. Chak's most frequent co-authors are Prasad Ganapathy Iyer, MD, Apoorva Krishna Chandar, MD, MPH and John Adam Dumot, DO.

Dmand AI links Dr. Chak to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Hereditary pancreatitis and Peutz-Jeghers Syndrome. Open Payments lists research payments to Dr. Chak that name 1 trial.

CMS Open Payments shows 87 general payments to Dr. Chak from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Lucid Diagnostics Inc. paid the most, $30,437. It also lists 5 research payments totaling $31,500 from 2017 to 2018, naming 1 clinical trial.